Canada markets closed

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
269.22-2.98 (-1.09%)
As of 11:08AM CST. Market open.
Currency in CNY

Valuation Measures4

Market Cap (intraday) 330.03B
Enterprise Value 310.62B
Trailing P/E 29.08
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.59
Price/Book (mrq)8.96
Enterprise Value/Revenue 9.04
Enterprise Value/EBITDA 24.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.08
52-Week Change 3-9.72%
S&P500 52-Week Change 321.23%
52 Week High 3325.00
52 Week Low 3253.48
50-Day Moving Average 3286.94
200-Day Moving Average 3282.37

Share Statistics

Avg Vol (3 month) 33.82M
Avg Vol (10 day) 33.84M
Shares Outstanding 51.21B
Implied Shares Outstanding 61.21B
Float 8488.65M
% Held by Insiders 158.01%
% Held by Institutions 118.68%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 48.8
Forward Annual Dividend Yield 43.23%
Trailing Annual Dividend Rate 38.80
Trailing Annual Dividend Yield 33.23%
5 Year Average Dividend Yield 4N/A
Payout Ratio 448.08%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 22, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 32.99%
Operating Margin (ttm)45.70%

Management Effectiveness

Return on Assets (ttm)16.72%
Return on Equity (ttm)33.83%

Income Statement

Revenue (ttm)34.37B
Revenue Per Share (ttm)28.40
Quarterly Revenue Growth (yoy)11.20%
Gross Profit (ttm)N/A
EBITDA 13.1B
Net Income Avi to Common (ttm)11.34B
Diluted EPS (ttm)9.36
Quarterly Earnings Growth (yoy)20.50%

Balance Sheet

Total Cash (mrq)19.67B
Total Cash Per Share (mrq)16.25
Total Debt (mrq)261.02M
Total Debt/Equity (mrq)0.71%
Current Ratio (mrq)2.79
Book Value Per Share (mrq)30.42

Cash Flow Statement

Operating Cash Flow (ttm)13.17B
Levered Free Cash Flow (ttm)6.4B